Home > ADHD Antipsychotic Research
ADHD & Antipsychotic Research
Landmark JAMA Study by Dr. Sultan
By Dr. Ryan Sultan, Columbia University Psychiatrist & ADHD Specialist
Last Updated: February 16, 2026
Quick Answer: Dr. Sultan's JAMA research found many youth with ADHD receive antipsychotics without FDA-approved indications. Antipsychotics are appropriate only for severe aggression or comorbid conditions (psychosis, bipolar), not for core ADHD symptoms.
🔬 The Research: A Critical Finding
As a Columbia University psychiatrist who researches and treats ADHD, I led a study that revealed a troubling pattern in pediatric psychiatry: many youth with ADHD were being prescribed antipsychotic medications without clear medical justification.
Publication: "Assessment of Prescribing of Antipsychotic Medications for Youths With Attention-Deficit/Hyperactivity Disorder"
Journal: JAMA Network Open, 2019
Lead Author: Ryan S. Sultan, MD
Citations: 411+ (as of 2026)
Impact: Influenced prescribing guidelines and clinical practice nationally
What we found: A significant proportion of youth with ADHD were prescribed second-generation antipsychotics (like risperidone, aripiprazole, quetiapine) without having FDA-approved indications for these medications.
This research sparked national conversations about appropriate prescribing practices, medication safety in youth, and the need for evidence-based treatment algorithms.
💊 What Are Antipsychotics?
Overview:
Antipsychotic medications (also called "neuroleptics") were originally developed to treat psychosis (hallucinations, delusions) in conditions like schizophrenia. They work primarily by blocking dopamine D2 receptors.
Second-Generation Antipsychotics (SGAs):
The medications most commonly prescribed to youth include:
- Risperidone (Risperdal) - Most commonly prescribed SGA in youth
- Aripiprazole (Abilify) - Partial dopamine agonist
- Quetiapine (Seroquel) - Often prescribed off-label for sleep or anxiety
- Olanzapine (Zyprexa) - High metabolic risk
- Lurasidone (Latuda) - Approved for bipolar depression in adolescents
FDA-Approved Uses in Youth:
Antipsychotics have narrow, specific FDA approvals in children and adolescents:
- Schizophrenia (ages 13+)
- Bipolar disorder (mania or mixed episodes, ages 10+)
- Autism spectrum disorder with severe irritability/aggression (ages 5+, risperidone and aripiprazole only)
- Tourette syndrome (tics, ages 6+, select medications)
Notably absent: ADHD is NOT an FDA-approved indication for any antipsychotic.
⚠️ The Problem: Off-Label Prescribing Without Clear Indication
What Our Research Found:
Key Finding: Many youth with ADHD were prescribed antipsychotics without documented diagnoses that would justify antipsychotic use (no schizophrenia, bipolar disorder, or autism).
Possible explanations for this pattern:
1. "Chemical Restraint" for Behavioral Control:
- Antipsychotics have sedating effects
- Can suppress hyperactivity and aggression through sedation and dopamine blockade
- Sometimes prescribed to "calm down" difficult-to-manage youth
- Problem: Treating symptoms without addressing root cause
2. Treatment-Resistant Aggression:
- Some youth with ADHD exhibit severe, persistent aggression
- When stimulants, behavioral therapy, and mood stabilizers fail, clinicians may turn to antipsychotics
- Legitimate in some cases, but should be last resort after comprehensive evaluation
3. Comorbid Conditions (Undiagnosed or Undocumented):
- Youth may have undiagnosed bipolar disorder, psychosis, or severe mood dysregulation
- Antipsychotic may be appropriate, but documentation doesn't capture full clinical picture
- Highlights need for thorough diagnostic assessment
4. Off-Label Use for Sleep or Anxiety:
- Quetiapine (Seroquel) often prescribed off-label for insomnia
- Problem: Antipsychotics are not first-line (or even second-line) sleep aids
- Safer alternatives exist (melatonin, behavioral sleep hygiene, alpha agonists)
🚨 Why This Matters: Risks of Antipsychotics in Youth
Antipsychotics are powerful medications with significant side effects, especially in children and adolescents:
1. Metabolic Side Effects:
- Weight gain: Average 10-15 pounds, sometimes much more
- Increased diabetes risk: Impaired glucose metabolism
- Dyslipidemia: Elevated cholesterol and triglycerides
- Metabolic syndrome: Cluster of risk factors for heart disease
Youth are particularly vulnerable because:
- Rapid weight gain during critical developmental periods
- Metabolic changes may persist even after discontinuation
- Long-term cardiovascular consequences
2. Neurological Side Effects:
- Sedation and cognitive dulling: Impairs school performance
- Extrapyramidal symptoms (EPS): Muscle stiffness, tremor, restlessness
- Tardive dyskinesia: Involuntary movements (potentially irreversible)
- Risk increases with duration of use
3. Hormonal Side Effects:
- Elevated prolactin: Causes breast development in boys (gynecomastia), irregular periods in girls
- Sexual side effects: Decreased libido, erectile dysfunction
- Impact on puberty and development
4. Cardiac Risks:
- QT prolongation: Increases risk of dangerous heart rhythms
- Requires ECG monitoring
- Drug interactions with other QT-prolonging medications
5. Psychological Effects:
- Emotional blunting ("I don't feel like myself")
- Anhedonia (reduced pleasure/motivation)
- Social withdrawal
Bottom Line: These risks are acceptable when treating serious conditions like schizophrenia or bipolar disorder—conditions that cause severe impairment. But they're NOT acceptable for routine behavioral management or as substitutes for proper ADHD treatment.
✅ When ARE Antipsychotics Appropriate for Youth with ADHD?
Despite the concerns, there are situations where antipsychotics are appropriate:
1. Comorbid Psychotic Disorder:
- Youth with both ADHD and schizophrenia or schizoaffective disorder
- Antipsychotic treats psychosis; stimulant treats ADHD
- Clear medical necessity
2. Comorbid Bipolar Disorder:
- Youth with ADHD and bipolar I disorder (mania/mixed episodes)
- Antipsychotic is mood stabilizer; may also help ADHD symptoms
- Stimulants can destabilize bipolar disorder, so antipsychotic may be preferred
3. Autism Spectrum Disorder with Severe Irritability/Aggression:
- FDA-approved use for risperidone and aripiprazole
- Youth may also have comorbid ADHD
- Antipsychotic addresses aggression that hasn't responded to behavioral interventions
4. Severe, Treatment-Resistant Aggression:
- Youth with ADHD and extreme aggression/explosive behavior
- After optimizing ADHD treatment (stimulants, alpha agonists)
- After evidence-based behavioral therapy (parent training, anger management)
- After ruling out environmental triggers (abuse, trauma, family dysfunction)
- Last resort when safety is at risk and all other options exhausted
5. Acute Crisis Stabilization:
- Short-term use during psychiatric emergency (severe agitation, danger to self/others)
- Time-limited—days to weeks, not months to years
- Reassess need frequently
🎯 The Right Approach: Treatment Algorithm for ADHD with Aggression
If a youth with ADHD exhibits significant aggression or behavioral dyscontrol, here's the evidence-based approach:
| Step |
Intervention |
Rationale |
| 1. Optimize ADHD Treatment |
Stimulant medication (methylphenidate or amphetamine) at adequate dose |
Untreated ADHD → impulsivity → aggression. Treating ADHD often reduces aggression. |
| 2. Add Behavioral Therapy |
Parent training (e.g., Parent-Child Interaction Therapy), anger management, social skills training |
Teaches coping skills, emotional regulation, and conflict resolution. |
| 3. Consider Alpha Agonists |
Guanfacine (Intuniv) or clonidine (Kapvay) |
FDA-approved for ADHD, reduce impulsivity and aggression, improve frustration tolerance. |
| 4. Evaluate for Comorbidities |
Screen for mood disorders (bipolar, depression), anxiety, trauma, learning disabilities |
Aggression may be symptom of untreated condition. Treat the root cause. |
| 5. Consider Mood Stabilizers |
Lithium, valproate, lamotrigine (if bipolar or severe mood lability) |
Target mood dysregulation without antipsychotic side effects. |
| 6. Assess Environment |
Family dysfunction, trauma, abuse, bullying, academic failure |
Address environmental stressors contributing to aggression. |
| 7. Antipsychotic (Last Resort) |
Risperidone or aripiprazole at lowest effective dose |
Only after Steps 1-6 exhausted. Use time-limited trials. Monitor side effects closely. |
Key principle: Antipsychotics should be the last step, not the first. Too often, they're prescribed prematurely without exhausting safer, evidence-based alternatives.
📊 Clinical Implications of Our Research
Our research at Columbia has influenced clinical practice in several ways:
1. Increased Scrutiny of Prescribing Practices:
- Hospitals and clinics now audit antipsychotic prescribing in youth
- Requirement for documented justification before prescribing
- Peer review of off-label antipsychotic prescriptions
2. Guideline Updates:
- American Academy of Child and Adolescent Psychiatry (AACAP) emphasizes conservative antipsychotic use
- Requires attempting behavioral interventions and optimizing ADHD treatment first
- Mandates metabolic monitoring (weight, glucose, lipids) if antipsychotic prescribed
3. Insurance Prior Authorization:
- Many insurers now require prior authorization for antipsychotics in youth
- Must document failed trials of first-line treatments
- Reduces inappropriate prescribing
4. Informed Consent:
- Clinicians must discuss risks and benefits with families
- Families empowered to ask questions and advocate for evidence-based care
💡 What Parents Should Know
If your child with ADHD is prescribed an antipsychotic, ask these questions:
- "What specific condition is this medication treating?"
- There should be a clear diagnosis (bipolar disorder, psychosis, severe aggression) beyond ADHD alone
- "Have we optimized ADHD treatment first?"
- Has your child tried stimulants at adequate doses? Non-stimulants? Alpha agonists?
- "Have we tried behavioral interventions?"
- Parent training, therapy, school accommodations?
- "What are the side effects, and how will we monitor for them?"
- Weight, metabolic labs, movement disorders, hormonal effects
- "Is this a time-limited trial, or long-term treatment?"
- Antipsychotics should be re-evaluated regularly (every 3-6 months minimum)
- "What happens if we don't use this medication?"
- Understand the risks of untreated symptoms vs. medication side effects
Remember: You have the right to ask questions, seek second opinions, and advocate for your child. A good psychiatrist will welcome these conversations and provide clear, evidence-based reasoning.
🎓 My Approach as a Clinician
In my practice at Columbia University, I follow these principles:
1. ADHD First:
- Optimize ADHD treatment before considering other medications
- Many behavioral problems resolve when ADHD is properly treated
2. Behavioral Interventions:
- Evidence-based therapy (CBT, parent training, social skills) as foundation
- Medication supports therapy, doesn't replace it
3. Diagnostic Clarity:
- Thorough evaluation to identify all conditions (not just ADHD)
- ADHD often coexists with anxiety, depression, learning disabilities
- Treat the full clinical picture
4. Conservative Prescribing:
- Use medications with best evidence and safety profiles first
- Antipsychotics reserved for clear indications
5. Informed Consent:
- Discuss risks, benefits, and alternatives with patients and families
- Shared decision-making
6. Close Monitoring:
- If antipsychotic prescribed, monitor weight, metabolic labs, and neurological side effects
- Regular reassessment of need
You can hear me discuss these principles on the ADHD reWired podcast episode: "Why Treat ADHD?"
✅ Bottom Line
Key takeaways from our research:
- Antipsychotics are NOT first-line treatment for ADHD. Stimulants and non-stimulants are.
- Antipsychotics have significant side effects (metabolic, neurological, hormonal) that must be weighed against benefits.
- Off-label prescribing requires clear justification—not just "behavioral control."
- Appropriate uses exist: comorbid psychosis/bipolar, severe treatment-resistant aggression, autism with irritability.
- Comprehensive treatment approach: Optimize ADHD treatment, behavioral therapy, address comorbidities BEFORE considering antipsychotics.
- Families should advocate: Ask questions, understand rationale, ensure evidence-based care.
Our research has helped bring attention to this issue and improve prescribing practices. The goal isn't to demonize antipsychotics—they're valuable tools when used appropriately—but to ensure they're prescribed thoughtfully, with clear medical justification, and only after safer alternatives have been tried.
📖 Related Content
About the Author:
Dr. Ryan Sultan is a board-certified psychiatrist at Columbia University and ADHD specialist. His research on psychopharmacology and prescribing practices has been published in JAMA Network Open and cited 411+ times.
← Back to Home |
About Dr. Sultan |
Publications